Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Launay-Vacher

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Clinical Nephrology|May 25, 2005
COX-2 inhibitors and acute interstitial nephritis: case report and review of the literatureJ B Esteve, V Launay-Vacher, I Brocheriou, et al.
Journal Des Maladies Vasculaires|December 29, 2016
Renal function and venous thromboembolic diseasesN Janus, I Mahé, V Launay-Vacher, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 26, 2005
PPAR-gamma-agonists' renal effectsH Izzedine, V Launay-Vacher, I Buhaescu, et al.
Medecine Et Maladies Infectieuses|November 13, 2007
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency]N Janus, V Launay-Vacher, H Izzedine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Drug-drug interactions associated with kinase inhibitors: highlighting a new resource for oncologists and clinical pharmacistsH Gelderblom, C H Köhne, V Launay-Vacher, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|June 14, 2003
Assessing residents' prescribing behavior in renal impairmentL Salomon, S Levu, G Deray, et al.
AIDS (London, England)|October 8, 1999
Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiencyH Izzedine, B Diquet, V Launay-Vacher, et al.
AIDS (London, England)|April 24, 2001
ABT 378/r: a novel inhibitor of HIV-1 protease in haemodialysisH Izzedine, V Launay-Vacher, M Legrand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 27, 2001
Gabapentin neurotoxicity in a chronic haemodialysis patientN Bassilios, V Launay-Vacher, N Khoury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?J Ayllon, V Launay-Vacher, J Medioni, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Nephrology|May 25, 2005
COX-2 inhibitors and acute interstitial nephritis: case report and review of the literatureJ B Esteve, V Launay-Vacher, I Brocheriou, et al.
Journal Des Maladies Vasculaires|December 29, 2016
Renal function and venous thromboembolic diseasesN Janus, I Mahé, V Launay-Vacher, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 26, 2005
PPAR-gamma-agonists' renal effectsH Izzedine, V Launay-Vacher, I Buhaescu, et al.
Medecine Et Maladies Infectieuses|November 13, 2007
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency]N Janus, V Launay-Vacher, H Izzedine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Drug-drug interactions associated with kinase inhibitors: highlighting a new resource for oncologists and clinical pharmacistsH Gelderblom, C H Köhne, V Launay-Vacher, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|June 14, 2003
Assessing residents' prescribing behavior in renal impairmentL Salomon, S Levu, G Deray, et al.
AIDS (London, England)|October 8, 1999
Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiencyH Izzedine, B Diquet, V Launay-Vacher, et al.
AIDS (London, England)|April 24, 2001
ABT 378/r: a novel inhibitor of HIV-1 protease in haemodialysisH Izzedine, V Launay-Vacher, M Legrand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 27, 2001
Gabapentin neurotoxicity in a chronic haemodialysis patientN Bassilios, V Launay-Vacher, N Khoury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2009
Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?J Ayllon, V Launay-Vacher, J Medioni, et al.
Pageof 6